[Inhibition of experimental thrombosis by combined administration of acetylsalicylic acid and cumarins].
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D007601:Jugular Veins; D008297:Male; D011817:Rabbits; D013924:Thrombophlebitis / Q000517:prevention & control*
D000925:Anticoagulants; D001593:Benzyl Compounds; D003374:Coumarins; D004338:Drug Combinations; D001241:Aspirin
Verhindeerung von experimenteller Thrombose durch die kombinierte Anwendung von Acetylsalicylsäure und Cumarinen.